Noninvasive Cortical Neurostimulation For Diabetic Neuropathic Pain

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Diabetic Neuropathy, PainfulDiabetes Mellitus, Type 1
Interventions
DEVICE

Sooma Oy (tDCS), Helsinki, Finland

Using the 2-channel neuro-stimulator Sooma tDCS equipment we provide 20 minutes of 2 mA anodal stimulation of the primary motor cortex (M1)

DEVICE

Sooma Oy (Sham), Helsinki, Finland

For the sham treatment, an electrical current will also be increased from 0 mA to 2 mA over the first 30 seconds, however, the current will be ramped back down to 0 mA after the initial ramp-up phase and no stimulation is delivered for the rest of the treatment.

Trial Locations (1)

9000

RECRUITING

Aalborg University Hospital, Aalborg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

Vissing fonden

UNKNOWN

lead

Jens Brøndum Frøkjær

OTHER